skip to main content
Idioma:
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Journals@Ovid Ovid Full Text remover tipo de recurso: Anais de Congresso remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997. Discussion
Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997. Discussion
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997. Discussion

HEALD, R. J ; MORAN, B. J ; RYALL, R. D. H ; SEXTON, R ; MACFARLANE, J. K ; WONG, J. H ; SCHROCK, t. R ; SWANSTROM, L. L ; WAGMAN, L. D ; RUSSELL, T. R

Archives of surgery (Chicago, IL. 1960), 1998, Vol.133 (8), p.894-899

Chicago, IL: American Medical Association

Texto completo disponível

Citações Citado por
2
OP0060 CLINICAL CONSEQUENCES OF INFLIXIMAB IMMUNOGENICITY AND THE IMPACT OF THERAPEUTIC DRUG MONITORING: SECONDARY ANALYSES OF A RANDOMISED CLINICAL TRIAL
OP0060 CLINICAL CONSEQUENCES OF INFLIXIMAB IMMUNOGENICITY AND THE IMPACT OF THERAPEUTIC DRUG MONITORING: SECONDARY ANALYSES OF A RANDOMISED CLINICAL TRIAL
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

OP0060 CLINICAL CONSEQUENCES OF INFLIXIMAB IMMUNOGENICITY AND THE IMPACT OF THERAPEUTIC DRUG MONITORING: SECONDARY ANALYSES OF A RANDOMISED CLINICAL TRIAL

Brun, M K ; Bjørlykke, K H ; Gehin, J E ; Warren, D J ; Klaasen, R A ; Sexton, J ; Sandanger, Ø ; Kvien, T K ; Mørk, C ; Jahnsen, J ; Bolstad, N ; Jørgensen, K K ; Haavardsholm, E A ; Goll, G L ; Syversen, S W

Annals of the rheumatic diseases, 2023, Vol.82 (Suppl 1), p.40-40 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
3
RISK OF HAEMATOLOGICAL MALIGNANCY IN PATIENTS WITH PSORIATIC ARTHRITIS, OVERALL AND IN RELATION TO TNF INHIBITORS - A NORDIC COHORT STUDY
RISK OF HAEMATOLOGICAL MALIGNANCY IN PATIENTS WITH PSORIATIC ARTHRITIS, OVERALL AND IN RELATION TO TNF INHIBITORS - A NORDIC COHORT STUDY
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

RISK OF HAEMATOLOGICAL MALIGNANCY IN PATIENTS WITH PSORIATIC ARTHRITIS, OVERALL AND IN RELATION TO TNF INHIBITORS - A NORDIC COHORT STUDY

Cordtz, R ; Askling, J ; Delcoigne, B ; Smedby, KE ; Baecklund, E ; Ballegaard, C ; Isomaki, P ; Aaltonen, K ; Gudbjornsson, B ; Love, T ; Provan, SA ; Michelsen, B ; Sexton, J ; Dreyer, L ; Hellgren, K

ANNALS OF THE RHEUMATIC DISEASES, 2022, Vol.81, p.169 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
6 and 12-month Drug Retention Rates and Treatment Outcomes in 941 Patients with Axial Spondyloarthritis Treated with Secukinumab in Routine Clinical Practice in 12 European Countries in the EuroSpA Research Collaboration Network
6 and 12-month Drug Retention Rates and Treatment Outcomes in 941 Patients with Axial Spondyloarthritis Treated with Secukinumab in Routine Clinical Practice in 12 European Countries in the EuroSpA Research Collaboration Network
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

6 and 12-month Drug Retention Rates and Treatment Outcomes in 941 Patients with Axial Spondyloarthritis Treated with Secukinumab in Routine Clinical Practice in 12 European Countries in the EuroSpA Research Collaboration Network

Michelsen, B ; Askling, J ; Codreanu, C ; Mann, H ; Loft, AG ; Pombo-Suarez, M ; Rotar, Z ; Kvien, T ; Santos, MJ ; Hokkanen, AM ; Lannone, F ; Gudbjornsson, B ; Onen, F ; Jacobsson, L ; Ionescu, R ; Pavelka, K ; Sanchez-Piedra, C ; Tomsic, M ; Sexton, J ; Santos, H ; Osterlund, J ; Cauli, A ; Geirsson, AJ ; Akar, S ; Ciurea, A ; Jones, G ; van der Horst-Bruinsma, I ; Brahe, CH ; Georgiadis, S ; Ornbjerg, LM ; Ostergaard, M ; Hetland, ML

ARTHRITIS & RHEUMATOLOGY, 2019, Vol.71 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Secukinumab Effectiveness in 1134 Patients with Psoriatic Arthritis Treated in Routine Clinical Practice in 11 European Countries in the EuroSpA Research Collaboration Network
Secukinumab Effectiveness in 1134 Patients with Psoriatic Arthritis Treated in Routine Clinical Practice in 11 European Countries in the EuroSpA Research Collaboration Network
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Secukinumab Effectiveness in 1134 Patients with Psoriatic Arthritis Treated in Routine Clinical Practice in 11 European Countries in the EuroSpA Research Collaboration Network

Michelsen, B ; DiGuiseppe, D ; Loft, AG ; Pombo-Suarez, M ; Mann, H ; Rotar, Z ; Iannone, F ; Kvien, T ; Santos, MJ ; Eklund, KK ; Gudbjornsson, B ; Codreanu, C ; Yilmaz, S ; Askling, J ; Sanchez-Piedra, C ; Pavelka, K ; Tomsic, M ; Conti, F ; Sexton, J ; Santos, H ; Trokovic, N ; Love, TJ ; Ionescu, R ; Pehlivan, Y ; Nissen, MJ ; Macfarlane, G ; van der Horst-Bruinsma, I ; Georgiadis, S ; Ornbjerg, LM ; Brahe, CH ; Hetland, ML ; Ostergaard, M

ARTHRITIS & RHEUMATOLOGY, 2019, Vol.71 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Does Retention and Remission Rates to 2nd and 3rd TNF Inhibitors in Patients with Axial Spondyloarthritis Depend on the Reason from Withdrawal to the Previous Treatment? - Real World Data from 12 European Countries in the EuroSpA Research Collaboration
Does Retention and Remission Rates to 2nd and 3rd TNF Inhibitors in Patients with Axial Spondyloarthritis Depend on the Reason from Withdrawal to the Previous Treatment? - Real World Data from 12 European Countries in the EuroSpA Research Collaboration
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Does Retention and Remission Rates to 2nd and 3rd TNF Inhibitors in Patients with Axial Spondyloarthritis Depend on the Reason from Withdrawal to the Previous Treatment? - Real World Data from 12 European Countries in the EuroSpA Research Collaboration

Ornbjerg, LM ; Brahe, CH ; Loft, AG ; Askling, J ; Ciurea, A ; Mann, H ; Akar, S ; Kristianslund, E ; Nordstrom, D ; Santos, MJ ; Codreanu, C ; Pombo-Suarez, M ; Rotar, Z ; Gudbjornsson, B ; DiGuiseppe, D ; Nissen, MJ ; Pavelka, K ; Senel, S ; Sexton, J ; Eklund, KK ; Barcelos, A ; Ionescu, R ; Sanchez-Piedra, C ; Tomsic, M ; Geirsson, AJ ; van der Horst-Bruinsma, I ; Macfarlane, G ; Iannone, F ; Michelsen, B ; Hyldstrup, L ; Krogh, NS ; Hetland, ML ; Ostergaard, M

ARTHRITIS & RHEUMATOLOGY, 2019, Vol.71 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Predicting ASDAS Inactive Disease After 6 Months of TNFi Treatment in Bio-Naive Axial Spondyloarthritis Patients Treated in Clinical Practice - Results from the EuroSpA Collaboration
Predicting ASDAS Inactive Disease After 6 Months of TNFi Treatment in Bio-Naive Axial Spondyloarthritis Patients Treated in Clinical Practice - Results from the EuroSpA Collaboration
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Predicting ASDAS Inactive Disease After 6 Months of TNFi Treatment in Bio-Naive Axial Spondyloarthritis Patients Treated in Clinical Practice - Results from the EuroSpA Collaboration

Ornbjerg, LM ; Georgiadis, S ; Lindstrom, U ; Loft, AG ; Ciurea, A ; Mann, H ; Akkoc, N ; Iannone, F ; Kristianslund, E ; Hokkanen, AM ; Santos, MJ ; Codreanu, C ; Sanchez-Piedra, C ; Tomsic, M ; Gudbjornsson, B ; van der Horst-Bruinsma, I ; Askling, J ; Nissen, MJ ; Pavelka, K ; Gunduz, O ; Atzeni, F ; Sexton, J ; Nordstrom, D ; Santos, H ; Ionescu, R ; Pombo-Suarez, M ; Rotar, Z ; Geirsson, AJ ; van de Sande, M ; Macfarlane, G ; Michelsen, B ; Hetland, ML ; Ostergaard, M

ARTHRITIS & RHEUMATOLOGY, 2019, Vol.71 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Patient Reported Outcomes over Time in 25,988 Axial Spondyloarthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Clinical Practice - Is PRO Remission Achieved? Results from the EuroSpA Collaboration
Patient Reported Outcomes over Time in 25,988 Axial Spondyloarthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Clinical Practice - Is PRO Remission Achieved? Results from the EuroSpA Collaboration
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Patient Reported Outcomes over Time in 25,988 Axial Spondyloarthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Clinical Practice - Is PRO Remission Achieved? Results from the EuroSpA Collaboration

Ornbjerg, LM ; Askling, J ; Loft, AG ; Nissen, MJ ; Mann, H ; Direskeneli, H ; Iannone, F ; Sexton, J ; Nordstrom, D ; Santos, MJ ; Codreanu, C ; Pombo-Suarez, M ; Rotar, Z ; Gudbjornsson, B ; Van der Horst-Bruinsma, I ; Lindstrom, U ; Ciurea, A ; Pavelka, K ; Yilmaz, N ; Gremese, E ; Kristianslund, E ; Hokkanen, AM ; Barcelos, A ; Ionescu, R ; Sanchez-Piedra, C ; Tomsic, M ; Geirsson, AJ ; van de Sande, M ; Macfarlane, G ; Brahe, CH ; Hetland, ML ; Ostergaard, M

ARTHRITIS & RHEUMATOLOGY, 2019, Vol.71 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Anti-Phosphorylcholine IgG Antibodies Reduce Restenosis and Vascular Inflammation by Inhibition of the Unfolded Protein Response in a Mouse Model of Accelerated Atherosclerosis
Anti-Phosphorylcholine IgG Antibodies Reduce Restenosis and Vascular Inflammation by Inhibition of the Unfolded Protein Response in a Mouse Model of Accelerated Atherosclerosis
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Anti-Phosphorylcholine IgG Antibodies Reduce Restenosis and Vascular Inflammation by Inhibition of the Unfolded Protein Response in a Mouse Model of Accelerated Atherosclerosis

Ewing, M ; Karabina, S ; Pettersson, K ; Atout, R ; De Vries, M ; Sexton, D ; Lettesjo, H ; Frostegard, J ; Jukema, JW ; Ninio, E ; Quax, P

CIRCULATION, 2010, Vol.122 (21) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
Passive immunization with anti-phosphorylcholine IgG antibodies reduces neointimal formation and vascular inflammation in a mouse model for accelerated atherosclerosis
Passive immunization with anti-phosphorylcholine IgG antibodies reduces neointimal formation and vascular inflammation in a mouse model for accelerated atherosclerosis
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Passive immunization with anti-phosphorylcholine IgG antibodies reduces neointimal formation and vascular inflammation in a mouse model for accelerated atherosclerosis

Ewing, MM ; De Vries, MR ; Pettersson, K ; Frostegard, J ; Sexton, DJ ; Jukema, JW ; Quax, PHA

EUROPEAN HEART JOURNAL, 2010, Vol.31, p.158 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (10)

Data de Publicação 

De até
Refinar
  1. Antes de1998  (1)
  2. 1998Até1998  (1)
  3. 1999Até2009  (1)
  4. 2010Até2019  (7)
  5. Após 2019  (2)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.